Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiwerth

Showing results (261-270 of 321) with videos related to

Pageof 33
Sort By:
Current Neuropharmacology|May 4, 2016
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical ImplicationsPredrag Sikiric, Sven Seiwerth, Rudolf Rucman, et al.
Biomedicines|January 21, 2022
Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat GlaucomaTamara Kralj, Antonio Kokot, Mirna Zlatar, et al.
Journal of Pharmacological Sciences|September 27, 2008
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-systemRobert Klicek, Marko Sever, Bozo Radic, et al.
World Journal of Gastroenterology|August 7, 2023
Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effectLuka Kalogjera, Ivan Krezic, Ivan Maria Smoday, et al.
Vascular Pharmacology|March 7, 2018
Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157Jakša Vukojević, Marko Siroglavić, Katarina Kašnik, et al.
Digestive Diseases and Sciences|August 1, 1996
Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicityP Sikirić, S Seiwerth, Z Grabarević, et al.
Digestive Diseases and Sciences|March 1, 1997
Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stressP Sikirić, B Mazul, S Seiwerth, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as TherapySanja Strbe, Ivan Maria Smoday, Ivan Krezic, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A ReviewDanijel Matek, Irena Matek, Mladen Japjec, et al.
Life Sciences|February 8, 2011
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesionsSpomenko Ilic, Domagoj Drmic, Sandra Franjic, et al.
Pageof 33

Showing results (261-270 of 321) with videos related to

Sort By:
Pageof 33
Current Neuropharmacology|May 4, 2016
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical ImplicationsPredrag Sikiric, Sven Seiwerth, Rudolf Rucman, et al.
Biomedicines|January 21, 2022
Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat GlaucomaTamara Kralj, Antonio Kokot, Mirna Zlatar, et al.
Journal of Pharmacological Sciences|September 27, 2008
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-systemRobert Klicek, Marko Sever, Bozo Radic, et al.
World Journal of Gastroenterology|August 7, 2023
Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effectLuka Kalogjera, Ivan Krezic, Ivan Maria Smoday, et al.
Vascular Pharmacology|March 7, 2018
Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157Jakša Vukojević, Marko Siroglavić, Katarina Kašnik, et al.
Digestive Diseases and Sciences|August 1, 1996
Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicityP Sikirić, S Seiwerth, Z Grabarević, et al.
Digestive Diseases and Sciences|March 1, 1997
Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stressP Sikirić, B Mazul, S Seiwerth, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Innate Vascular Failure by Application of Neuroleptics, Amphetamine, and Domperidone Rapidly Induced Severe Occlusion/Occlusion-like Syndromes in Rats and Stable Gastric Pentadecapeptide BPC 157 as TherapySanja Strbe, Ivan Maria Smoday, Ivan Krezic, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A ReviewDanijel Matek, Irena Matek, Mladen Japjec, et al.
Life Sciences|February 8, 2011
Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesionsSpomenko Ilic, Domagoj Drmic, Sandra Franjic, et al.
Pageof 33